You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行》中金對醫療健康股投資評級及目標價(表)
中金髮表研究報告,對醫療健康股最新投資評級及目標價表列如下: 股份 | 投資評級 | 目標價(港元) 科倫博泰生物-B(06990.HK) | 跑贏行業 | 350元 康方生物(09926.HK) | 跑贏行業 | 120元 信達生物(01801.HK) | 跑贏行業 | 95.3元 再鼎醫藥(09688.HK) | 跑贏行業 | 34.41元 石藥集團(01093.HK) | 跑贏行業 | 8.6元 中國生物製藥(01177.HK) | 跑贏行業 | 7.6元 三生製藥(01530.HK) | 跑贏行業 | 26.1元 先聲藥業(02096.HK) | 跑贏行業 | 12.8元 遠大醫藥(00512.HK) | 跑贏行業 | 9.6元 藥明巨諾-B(02126.HK) | 跑贏行業 | 2.4元
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account